Mindfulness, Exercise, and Nutrition To Optimize Resilience (MENTOR)
ConditionDisabled Persons
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShirley Ryan AbilityLab
About this trial
The Mindfulness, Nutrition and Exercise to Optimize Resilience (MENTOR) program is offered through the National Center on Health, Physical Activity and Disability (NCHPAD). NCHPAD is funded by the Centers for Disease Control and Prevention (CDC), is a public health practice that offers health promotion programs and resources to people with mobility disabilities. The purpose of this project is to provide a free-of-charge wellness program designed to improve health and wellness for people with mobility and physical disability living in the United States.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Lives in the United States
People 18 years or older
A self-reported physical disability/mobility limitation (or use an assistive device such as an ankle foot orthosis, cane, walker, scooter, or wheelchair).
Have internet access and a mobile device (phone, tablet, laptop, desktop) to attend sessions.
Disqualifiers
Younger than 18 years old
Living outside of the United States
No physical disability/mobility limitation
No internet access
Trial design
Design model
Single group
Treatments tested in this trial
MENTOR
BehavioralParticipants will attend a group-based, 8-week online program (a total of 40 hours) via Zoom videoconferencing. The program is split into three wellness sections (Mindfulness, Exercise, and Nutrition) and eight other sections (self-care skills, core values, outdoor time in nature, rest/relaxation, contribution to others, arts and leisure, relationships, and spiritual practice). Participants will access all assessment and intervention tools on any mobile device (phone, tablet, laptop, desktop) using a password-protected identification (ID) to log in via their devices. Health coaches can create intake flows to collect health data and track analytics. Participants can see their goals, upcoming intervention sessions, and activities through the study application (app). Features of the study app include goal setting, where participants record their goals, zoom videoconferencing links for online classes and coaching sessions, and the ability to share materials with participants.
Treatment groups
300 Participants
are divided into 1 treatment groupGroup A: MENTOR Wellness ProgramExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Connor-Davidson Resilience Scale (CD-RISC)
This is a resilience measure to gain a better understanding of whether the program had any benefit to improving resilience. It consists of 10 items.The response scale has a 5-point range from 0 to 4. Scores are summed to provide a total score of 40, where higher scores indicate higher resilience. It measures the Effectiveness of the RE-AIM framework.
Time frame
Pre/Post 8-week ProgramSecondary outcomes
1
Godin Leisure-Time Exercise Questionnaire (GLTEQ)
A self-report measure of physical activity. It is a 7-day recall questionnaire that contains 3 questions pertaining to light, moderate, and vigorous intensity activity. The GLTEQ can be scored either by summing all 3 intensity types (Total Activity score) after multiplying each by 3, 5, and 9, respectively, or by summing moderate and vigorous activity only (Health Promotion score). It measures the Effectiveness of the RE-AIM framework.
Time frame
Pre/Post 8-week Program2
Mindfulness Attention Awareness Scale (MAAS)
This is a mindfulness scale which is used to identify potential changes in mindfulness. This scale contains 15 items that ask participants how frequently they have a certain experience, using a 6-point Likert scale from 1 to 6. The score is calculated by calculating the mean of these 15 items. Higher scores reflect more mindfulness. It measures the Effectiveness of the RE-AIM framework.
Time frame
Pre/Post 8-week Program3
NCHPAD Wellness Assessment (NWA)
This assessment has 3 dimensions which are physical, mental, and emotional/spiritual health. Each dimension has 5 questions, and an additional question assesses the overall wellness (16 questions total). The NWA is scored on a Likert scale from 1-5. Higher scores reflect better wellness. It measures the Effectiveness of the RE-AIM framework.
Time frame
Pre/Post 8-week Program4
Nutrition Questionnaire on Mindful Eating, Habits, and Knowledge
It is a survey to identify which dietary advice people find confusing. It consists of 3 domains: nutrition knowledge (24 items), mindful eating assessment (2 items), and eating habits (13 items).It measures the Effectiveness of the RE-AIM framework.
Time frame
Pre/Post 8-week ProgramOther outcomes
1
Proportion of individuals who express interest in MENTOR
This measure will be a proportion of contacted individuals who complete an eligibility survey. The proportion ranges from 0 to 100 percent. Higher percentages represent a higher reach. It measures the Reach domain in the RE-AIM framework.
Time frame
Pre Program (Week 1)2
Representativeness of individuals who express interest in MENTOR
The sociodemographic and medical characteristics of individuals will be reviewed. It measures the Reach domain in the RE-AIM framework.
Time frame
Pre Program (Week 1)3
Proportion of eligible participants who begin MENTOR
This will measure the proportion of eligible participants who consent, complete a baseline survey, and start MENTOR. The proportion ranges from 0 to 100 percent. Higher percents represent a higher adoption. It measures the Adoption component of the RE-AIM framework.
Time frame
Post Program (Week 8)4
Proportion of eligible participants who complete MENTOR
This will measure the proportion of eligible participants who retain and complete MENTOR. The proportion ranges from 0 to 100 percent. Higher percents represent a higher adoption. It measures the Adoption component of the RE-AIM framework.
Time frame
Post Program (Week 8)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Shirley Ryan AbilityLab
Lead sponsor
University of Alabama at Birmingham
Collaborator
Source ClinicalTrials.gov